Systemic effects of chronic obstructive pulmonary disease
about
Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkersPulmonary rehabilitation for chronic obstructive pulmonary diseaseNon-invasive ventilation during exercise training for people with chronic obstructive pulmonary diseaseNon-invasive ventilation during exercise training for people with chronic obstructive pulmonary diseaseModels of chronic obstructive pulmonary diseaseCan inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant skeletal muscleCOPD and levels of Hsp70 (HSPA1A) and Hsp27 (HSPB1) in plasma and lymphocytes among coal workers: a case-control studyA double blind randomized placebo control crossover trial on the effect of dietary nitrate supplementation on exercise tolerance in stable moderate chronic obstructive pulmonary disease.Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model.The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controlsGender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study.Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.Preclinical vascular disease identifies smokers at risk for COPD.A unique protein profile of peripheral neutrophils from COPD patients does not reflect cytokine-induced protein profiles of neutrophils in vitroPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypeDeterminants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease.Mobile-phone-based home exercise training program decreases systemic inflammation in COPD: a pilot studyAdipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking.Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort.The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls.Potential new drugs for therapy of chronic obstructive pulmonary disease.Airway inflammation contributes to health status in COPD: a cross-sectional study.Correlation of a decline in aerobic capacity with development of emphysema in patients with chronic obstructive pulmonary disease: a prospective observational study.Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in MiceDisturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosisLC-MS based metabolomics identification of novel biomarkers of tobacco smoke-induced chronic bronchitis.Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.High prevalence of emphysema and its association with BMI: a study of smokers with normal spirometry.Reproducibility and Validity of the 6-Minute Walk Test Using the Gait Real-Time Analysis Interactive Lab in Patients with COPD and Healthy ElderlyExecutive Function, Survival, and Hospitalization in Chronic Obstructive Pulmonary Disease. A Longitudinal Analysis of the National Emphysema Treatment Trial (NETT).Prevalence of airflow obstruction in patients with stable systolic heart failure.Analysis of three different equations for predicting quadriceps femoris muscle strength in patients with COPD.TNF-α is associated with loss of lean body mass only in already cachectic COPD patients
P2860
Q23919501-CA7EB9CA-A7DD-4C63-87F6-D614917D101AQ24187999-7110182B-BC64-485D-9AEB-B6B20D0AA2B7Q24194665-A3736C48-143E-4099-905C-B21890AC374AQ24241953-2FDAA963-DFA2-445E-869D-D65A5555300CQ24798450-2EA42EC4-C1AA-4842-8ADF-5B58B0258078Q25257397-2134C56E-D6F1-49D2-B4C2-2774EC13F72CQ28261758-A81B3D6B-34FB-4591-A67A-7B0D2A515E0DQ28392377-3F39A355-4554-45CB-9C89-DF8F8B9D80FBQ30648825-59E9EA3B-C513-443C-BD0B-48580F4AD25FQ31108866-A2A4B99A-6075-4A6D-BD1D-335D8813DF5CQ33498530-367CB349-801B-44D0-B934-E8C547E9E50DQ33634631-051421A3-E5F2-41BE-8880-D1FF5C42BC58Q33803872-28C0E887-4086-4EA8-A5A9-6EBD6B596652Q33880491-59E1C0C5-DEC5-4DD5-A6EE-E00979852858Q33928645-8D50786B-A308-4292-9234-9D80A1B207CDQ34012362-1C046144-66C7-4A64-A625-77D077C59018Q34280020-CD2EFBFF-5951-481A-9B3A-90312FDFDCE7Q34287954-9A24A1AA-9CD1-4FB3-91EF-695F2408C1F4Q34432112-9C601DA6-B851-449C-BC51-99F775623CA6Q34539050-31A521D5-05BC-4101-8CE3-8E256AEC6F57Q34580025-6091B72B-1BB9-42B2-9DC2-5895788D7EC6Q34625439-34A2D74F-AFC7-4567-8C5D-A31905B853C4Q34684222-3732A64F-8A98-4172-839A-327FD91E4C0BQ34914760-52EE5E52-DCA3-4629-9427-33F251FE4434Q35058473-4AB87CC0-BF94-46F8-8E0C-FE3DAEA5428EQ35097330-A8126633-0BCA-415E-B1E3-C8C43D6B721EQ35164728-A50952E5-5697-4C28-B781-CEE277E0A418Q35220025-75C05149-55D1-412B-834A-673B94F5CADDQ35536473-E8B82388-0237-4364-A083-9ACF0AF48A7DQ35658509-6CDD2726-E96C-4D3B-9C9B-140B83EF739CQ35677638-C960440A-BA3B-4FDA-9253-E7DCB26FD4E4Q35781857-0BED691C-9B6F-4CD2-A9FA-D9A43F445515Q35987189-EE045233-F485-4CC1-A709-46AA08383E18Q35996778-E2B081A2-DB89-40AB-852E-2B8AE4C2BC40Q36121998-9CDFA69B-DD18-4AF1-9B4F-0E8FB5B93613Q36126651-C3E1D4AC-6FA2-48DE-8001-A1BC92A87F69Q36232424-F34D5CE5-1B75-4382-86DD-B026EBA74FD4Q36243275-CE5B363D-CB24-4ABD-8703-B9E832B5B1FEQ36256581-EBF157E0-F60C-4A6F-96D3-80633DE1CAC8Q36367744-F70580E7-F7FA-401F-9EDC-E8F7D7CFE956
P2860
Systemic effects of chronic obstructive pulmonary disease
description
im Februar 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 February 2003
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2003
@uk
name
Systemic effects of chronic obstructive pulmonary disease
@en
Systemic effects of chronic obstructive pulmonary disease
@nl
type
label
Systemic effects of chronic obstructive pulmonary disease
@en
Systemic effects of chronic obstructive pulmonary disease
@nl
prefLabel
Systemic effects of chronic obstructive pulmonary disease
@en
Systemic effects of chronic obstructive pulmonary disease
@nl
P2093
P1476
Systemic effects of chronic obstructive pulmonary disease
@en
P2093
P304
P356
10.1183/09031936.03.00405703
P577
2003-02-01T00:00:00Z